Comparison of Type 2 Diabetes Pharmacotherapy Regimens

Exposure to the class of drugs known as Sulfonylureas (SU)

Exposure to the class of drugs known as Dipeptidyl peptidase-4 inhibitors (DPP4)

Exposure to the class of drugs known as Sodium-glucose cotransporter-2 inhibitors (SGLT2i)

Exposure to the class of drugs known as Glucagon-like peptide-1 receptor agonists (GLP-1RA)

Exposure to either SGLT2i or GLP-1RA

Exposure to agent Linagliptin (DPP4)

Exposure to agent Exenatide (GLP1-RA)

Exposure to agent Liraglutide (GLP-1RA)

Exposure to agent Empagliflozin (SGLT2i)

Exposure to agent Glimepiride (SU)

Exposure to Glimepiride (SU)

Exposure to agent Glimepiride (SU) or Glipizide (SU)

Exposure to either SU or DPP4 excluding Saxagliptin and Alogliptin

Exposure to either Exenatide (GLP-1RA) or Liraglutide (GLP-1RA)